Company profile for Cidara Therapeutics

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Cidara is developing therapeutics to improve the standard of care for patients facing severe fungal or viral infections. The Company’s portfolio is comprised of breakthrough approaches aimed at transforming existing treatment and prevention paradigms, first with its lead antifungal candidate, rezafungin, in addition to therapies targeting influenza and other viral diseases from Cidara’s proprietary Cloudbreak® platform. C...
Cidara is developing therapeutics to improve the standard of care for patients facing severe fungal or viral infections. The Company’s portfolio is comprised of breakthrough approaches aimed at transforming existing treatment and prevention paradigms, first with its lead antifungal candidate, rezafungin, in addition to therapies targeting influenza and other viral diseases from Cidara’s proprietary Cloudbreak® platform. Cidara is headquartered in San Diego, California.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
6310 Nancy Ridge Drive, Suite 101 San Diego, CA 92121
Telephone
Telephone
(858) 752-6170
youtube
YouTube

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

Global ChemShow

Not Confirmed

envelop Contact Supplier

Global ChemShow

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.globenewswire.com/news-release/2025/11/24/3193451/0/en/Cidara-Therapeutics-Reaches-Target-Enrollment-of-Phase-3-ANCHOR-Trial-Evaluating-CD388-for-Prevention-of-Seasonal-Influenza-in-High-Risk-Populations.html

GLOBENEWSWIRE
24 Nov 2025
Merck to Acquire Cidara Therapeutics
Merck to Acquire Cidara Therapeutics

14 Nov 2025

// BUSINESSWIRE

https://www.businesswire.com/news/home/20251114185276/en/Merck-to-Acquire-Cidara-Therapeutics-Inc.-Diversifying-Its-Portfolio-to-Include-Late-Phase-Antiviral-Agent

BUSINESSWIRE
14 Nov 2025

https://www.globenewswire.com/news-release/2025/11/06/3183153/0/en/Cidara-Therapeutics-Provides-Corporate-Update-and-Reports-Third-Quarter-2025-Financial-Results.html

GLOBENEWSWIRE
06 Nov 2025

https://www.globenewswire.com/news-release/2025/10/28/3175321/0/en/Cidara-Therapeutics-to-Participate-in-November-Investor-Conferences.html

GLOBENEWSWIRE
28 Oct 2025

https://www.globenewswire.com/news-release/2025/10/23/3172428/0/en/Cidara-Therapeutics-to-Report-Third-Quarter-2025-Financial-Results-and-Host-Quarterly-Conference-Call-on-November-6-2025.html

GLOBENEWSWIRE
23 Oct 2025

https://www.globenewswire.com/news-release/2025/10/23/3171959/0/en/Cidara-Therapeutics-Announces-Late-Breaking-Presentation-on-CD388-at-10%E1%B5%97%CA%B0-ESWI-Influenza-Conference-2025.html

GLOBENEWSWIRE
23 Oct 2025

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty